Overcoming the resistance to antiangiogenic therapy: Itraconazole blocks blood vessel maturation and synergizes with anti-VEGF therapy

被引：1
|
作者：
Fu, Chenglai [1 ]
Gerber, Stephanie [1 ]
Castillo, Richmond [1 ]
van der Zwan, Anita [1 ]
Kachhap, Sushant [1 ]
Hammers, Hans [1 ]
机构：
[1] Johns Hopkins Univ, Baltimore, MD USA
来源：
CANCER RESEARCH | 2013年 / 73卷 / 08期
关键词：
D O I：
10.1158/1538-7445.AM2013-5084
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5084
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Present Status of Anti-VEGF Therapy
    Schmidt-Erfurth, Ursula
    OPHTHALMOLOGICA, 2012, 228 : 53 - 54
  • [22] Anti-VEGF therapy in pituitary carcinoma
    Ortiz, Leon D.
    Syro, Luis V.
    Scheithauer, Bernd W.
    Ersen, Ayca
    Uribe, Humberto
    Fadul, Camilo E.
    Rotondo, Fabio
    Horvath, Eva
    Kovacs, Kalman
    PITUITARY, 2012, 15 (03) : 445 - 449
  • [23] ANTI-VEGF therapy for crescentic glomerulonephritis?
    Kitamoto, Yasunori
    Taguma, Yoshio
    Arizono, Kenji
    Imamura, Takahisa
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2008, 51 (04) : 710 - 711
  • [24] Anti-VEGF Therapy and the Retina: An Update
    Tah, Vikas
    Orlans, Harry O.
    Hyer, Jonathan
    Casswell, Edward
    Din, Nizar
    Shanmuganathan, Vishnu Sri
    Ramskold, Louise
    Pasu, Saruban
    JOURNAL OF OPHTHALMOLOGY, 2015, 2015
  • [25] Impact of vessel maturation on antiangiogenic therapy in ovarian cancer
    Lu, Chunhua
    Thaker, Premal H.
    Lin, Yvonne G.
    Spannuth, Whitney
    Landen, Charles N.
    Merritt, William M.
    Jennings, Nicholas B.
    Langley, Robert R.
    Gershenson, David M.
    Yancopoulos, George D.
    Ellis, Lee M.
    Jaffe, Robert B.
    Coleman, Robert L.
    Sood, Anil K.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2008, 198 (04) : 477.e1 - 477.e10
  • [26] Tumor refractoriness to anti-VEGF therapy
    Ribatti, Domenico
    ONCOTARGET, 2016, 7 (29) : 46668 - 46677
  • [27] Anti-VEGF Therapy in Myopic CNV
    Toto, Lisa
    Di Antonio, Luca
    Costantino, Olivia
    Mastropasqua, Rodolfo
    CURRENT DRUG TARGETS, 2021, 22 (09) : 1054 - 1063
  • [28] Disappointing outcomes for anti-VEGF therapy
    Lisa Richards
    Nature Reviews Clinical Oncology, 2011, 8 (4) : 194 - 194
  • [29] Anti-VEGF therapy in pituitary carcinoma
    Leon D. Ortiz
    Luis V. Syro
    Bernd W. Scheithauer
    Ayca Ersen
    Humberto Uribe
    Camilo E. Fadul
    Fabio Rotondo
    Eva Horvath
    Kalman Kovacs
    Pituitary, 2012, 15 : 445 - 449
  • [30] Chances and risks of anti-VEGF therapy
    Ziemssen, F.
    Heiduschka, P.
    Peters, S.
    Grisanti, S.
    Schraermeyer, U.
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2008, 225 (09) : 770 - 778
12345